FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Xbrane Refiles Lucentis Biosimilar BLA

[ Price : $8.95]

Xbrane Biopharma refiles a BLA for its investigational ranibizumab, a biosimilar copy of Genentechs age-related macular degenerati...

Alert on AquaFlexFlow Blood Circuits

[ Price : $8.95]

FDA issues a safety alert on Nuwellis AquaFlexFlow UF 500 Plus extracorporeal blood circuit because the device may trigger a weigh...

Senators Introduce Skinny Label Generic Drug Bill

[ Price : $8.95]

Four senators introduce bipartisan legislation to protect generic drug manufacturers from innovator drug lawsuits over skinny labe...

Syndax Leukemia Review Extended by FDA

[ Price : $8.95]

FDA extends by three months its review of a Syndax Pharmaceuticals NDA for revumenib and its use in treating adult and pediatric p...